Biomedical subjects
T Chard
Publications and source records attributed to T Chard.
Letter: Maternal alpha-fetoprotein and neural-tube defects.
Explore the source record for details and available documents.
Threatened abortion. Placental lactogen levels guide.
Explore the source record for details and available documents.
Placental lactogen levels in rhesus isoimmunization.
A prospective study of the plasma levels of human placental lactogen (HPL) in pregnancies complicated by rhesus isoimmunization showed that in mild and moderately affected cases the levels were normal, while in severely affected cases they were raised. Serial levels of HPL before the 26th week provide a valuable indication of fetal outcome, and we suggest that this estimation should be used routinely as an adjunct to other tests in the management of rhesus isoimmunization.
Observations on the use of solid-phase-coupled antibodies in the radioimmunoassay of human placental lactogen.
A detailed comparative assessment was made of the use of solid-phase-coupled antibodies in radioimmunoassay, by using an assay for human placental lactogen as a model system. The major advantages of the solid-phase technique are: (1) in common with the use of a second antibody, it is universally applicable; (2) separation can be carried out rapidly; (3) in contrast with some other techniques, the separation of antibody-bound and free antigen is virtually complete. The disadvantages when compared with other procedures are: (1) a considerable proportion of the antibody may be lost during the initial coupling reaction; (2) the tubes must be continuously mixed during incubation, and much effort is expended in removing and replacing the caps; (3) there is a decrease in the apparent affinity constant of the antibody after coupling, which is reflected in a lower sensitivity of the assay system. It is concluded that solid-phase antibodies are of greatest value in those systems in which the supply of antiserum is abundant, and in which the achievement of high sensitivity is not a requirement.
Radioimmunoassay and saturation analysis. Posterior pituitary peptides.
Explore the source record for details and available documents.
Circulating levels of prolactin during the menstrual cycle.
Explore the source record for details and available documents.
Technical aspects of the redox bioassay for luteinizing hormone.
Explore the source record for details and available documents.
Applications of the redox bioassay for luteinizing hormone.
Explore the source record for details and available documents.
Human placental lactogen levels in amniotic fluid in rhesus isoimmunization.
Explore the source record for details and available documents.
Reproducibility of measurement of fetal biparietal diameter by ultrasonic cephalometry.
Explore the source record for details and available documents.
Short-term variation in blood levels of prolactin, luteinizing hormone and follicle-stimulating hormone in normal men throughout the day.
Explore the source record for details and available documents.
Proceedings: In vitro use of radioisotopes as indicating placental function and-or fetal well-being.
Explore the source record for details and available documents.
Proceedings: Measurement and identification of gonadotrophins and their subunits in human maternal and foetal circulation around term.
Explore the source record for details and available documents.
The hormonal assessment of fetal and placental function.
Explore the source record for details and available documents.
A new bioassay for luteinizing hormone.
Explore the source record for details and available documents.
Placental lactogen levels during bed rest.
Explore the source record for details and available documents.
Proceedings: Modifications of the redox bioassay of luteinizing hormones.
Explore the source record for details and available documents.